Search Results for: Veterinary uses
indicated for treating dogs infested with demodex canis and sarcoptes scabiei var. canismites. madison, n.j., november 25, 2019 - msd animal health, a division of merck & co., inc., kenilworth, n.j., usa, today announced that following a positive opinion from the committee for medicinal products for veterinary
use (cvmp), the european commission has granted two additional indications of a marketing authorization for the veterinary medicinal product bravecto(r) (fluralaner) chew and bravecto(r) spot-on for dogs. the new therapeutic indications are for the treatment of demodectic (demodex canis) mites and sarcoptic...
https://www.msd-animal-health.com/2019/11/25/msd-animal-health-receives-european-marketing-authorization-for-additional-indications-of-bravecto-fluralaner-to-treat-harmful-mite-infestations-in-dogs/
indicated for treating dogs infested with demodex canis and sarcoptes scabiei var. canismites. madison, n.j., november 25, 2019 - msd animal health, a division of merck & co., inc., kenilworth, n.j., usa, today announced that following a positive opinion from the committee for medicinal products for veterinary
use (cvmp), the european commission has granted two additional indications of a marketing authorization for the veterinary medicinal product bravecto(r) (fluralaner) chew and bravecto(r) spot-on for dogs. the new therapeutic indications are for the treatment of demodectic (demodex canis) mites and sarcoptic...
https://www.msd-animal-health.com/2019/11/25/msd-animal-health-receives-european-marketing-authorization-for-additional-indications-of-bravecto-fluralaner-to-treat-harmful-mite-infestations-in-dogs/